Stockreport

Aprea Therapeutics Appoints Gregory S. Wessels as Vice President, Commercial

Aprea Therapeutics, Inc.  (APRE) 
PDF BOSTON, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing nov [Read more]